These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine. Epstein MA; Morgan AJ Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441 [No Abstract] [Full Text] [Related]
43. [Diagnosis of EBV infections using an immunologic method]. Mizuno F Nihon Rinsho; 1989 Feb; 47(2):367-71. PubMed ID: 2542659 [No Abstract] [Full Text] [Related]
44. [Relationships of Epstein-Barr virus to the Burkitt-tumor and to infectious mononucleosis]. Goetz O; Peller P Munch Med Wochenschr; 1970 Apr; 112(5):702-5. PubMed ID: 4329568 [No Abstract] [Full Text] [Related]
45. Clinical implications of immunity to oncogenic viruses. Levine PH Contemp Top Immunobiol; 1977; 6():263-86. PubMed ID: 194750 [No Abstract] [Full Text] [Related]
46. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma. Klein G Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586 [No Abstract] [Full Text] [Related]
47. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. Svedmyr A; Demissie A; Klein G; Clifford P J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428 [No Abstract] [Full Text] [Related]
48. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. Miller G; Niederman JC; Andrews LL N Engl J Med; 1973 Feb; 288(5):229-32. PubMed ID: 4345064 [No Abstract] [Full Text] [Related]
49. [Immunology of Epstein-Barr virus in lymphoproliferative diseases]. Bachmann AE; Giraudo Conesa LC; Braun M Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156 [No Abstract] [Full Text] [Related]
50. [Epstein-Barr virus]. Niller HH; Wolf H Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):118-25. PubMed ID: 8392849 [TBL] [Abstract][Full Text] [Related]
51. [The diagnostic value of Epstein-Barr virus diagnosis]. Bauer G Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107 [No Abstract] [Full Text] [Related]
52. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683 [TBL] [Abstract][Full Text] [Related]
56. [Epstein-Barr virus as an etiological factor in infectious mononucleosis and other diseases]. Kacprzak-Bergman I; Rudkowski Z Pediatr Pol; 1977 Nov; 52(11):1293-7. PubMed ID: 201912 [No Abstract] [Full Text] [Related]
57. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis]. Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV Lab Delo; 1989; (5):73-4. PubMed ID: 2473271 [TBL] [Abstract][Full Text] [Related]
58. Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma. Henle G; Henle W Bibl Haematol; 1975 Oct; (43):322-5. PubMed ID: 183692 [No Abstract] [Full Text] [Related]